Natixis Investment Managers International’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-56,793
Closed -$2.98M 402
2022
Q2
$2.98M Buy
56,793
+8,675
+18% +$442K 0.06% 91
2022
Q1
$2.49M Buy
+48,118
New +$2.5M 0.04% 110
2018
Q4
Sell
-93,655
Closed -$3.92M 427
2018
Q3
$3.92M Buy
93,655
+15,609
+20% +$601K 0.18% 85
2018
Q2
$2.69M Buy
78,046
+21,021
+37% +$718K 0.15% 96
2018
Q1
$1.92M Buy
+57,025
New +$1.96M 0.14% 100
2017
Q4
Sell
-42,763
Closed -$1.45M 306
2017
Q3
$1.45M Sell
42,763
-12,730
-23% -$409K 0.13% 116
2017
Q2
$1.77M Sell
55,493
-12,631
-19% -$398K 0.15% 96
2017
Q1
$2.21M Buy
68,124
+9,528
+16% +$300K 0.19% 78
2016
Q4
$1.81M Buy
58,596
+34,052
+139% +$1.04M 0.17% 92
2016
Q3
$789K Buy
24,544
+6,100
+33% +$204K 0.08% 168
2016
Q2
$616K Sell
18,444
-6,063
-25% -$194K 0.07% 205
2016
Q1
$689K Sell
24,507
-5,994
-20% -$171K 0.08% 127
2015
Q4
$934K Hold
30,501
0.12% 99
2015
Q3
$909K Buy
30,501
+694
+2% +$22.3K 0.12% 121
2015
Q2
$948K Sell
29,807
-1,834
-6% -$59.8K 0.12% 121
2015
Q1
$1.04M Sell
31,641
-5,032
-14% -$160K 0.13% 114
2014
Q4
$1.08M Buy
+36,673
New +$1.05M 0.14% 112

Other funds holding PFE

Natixis Investment Managers International's PFE Position: Q3 2022 in Review

Natixis Investment Managers International sold out of Pfizer (PFE) in Q3 2022, closing a stake of 56,793 shares — an estimated $2.98M sold.

Natixis Investment Managers International first reported a position in PFE in Q4 2014 and held it in 17 quarters. The position peaked at $3.92M in Q3 2018. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Natixis Investment Managers International reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 56,793 Pfizer shares in Q3 2022, an estimated $2.98M.
  • Natixis Investment Managers International first reported a position in Pfizer in Q4 2014 and held it in 17 quarters.
  • Natixis Investment Managers International's Pfizer position peaked at $3.92M in Q3 2018.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.